BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 7976882)

  • 1. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced color flows in hepatic tumors.
    Yang CC; Chen CH; Yeh YH
    Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of vascularity in hepatic tumors: comparison of power Doppler sonography and intraarterial CO(2)-enhanced sonography.
    Chen RC; Chen WT; Tu HY; Cheng NY; Wang CK; Liao LY; Wang CS; Chen PH
    AJR Am J Roentgenol; 2002 Jan; 178(1):67-73. PubMed ID: 11756089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow characteristics of hepatic tumors at color Doppler sonography: correlation with arteriographic findings.
    Numata K; Tanaka K; Mitsui K; Morimoto M; Inoue S; Yonezawa H
    AJR Am J Roentgenol; 1993 Mar; 160(3):515-21. PubMed ID: 8381573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
    Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
    J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors.
    Numata K; Tanaka K; Kiba T; Morimoto M; Arata S; Kondo M; Sekihara H
    AJR Am J Roentgenol; 1997 Apr; 168(4):991-5. PubMed ID: 9124156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Color Doppler sonography and resistivity index in the differential diagnosis of hepatic neoplasm.
    Nahar N; Khan N; Chakraborty RK; Rima SZ; Ara R; Islam SM; Mahmud S; Alam MN; Swapan K; Akhter M; Saleh FM; Alam MM; Alam MM
    Mymensingh Med J; 2014 Jan; 23(1):35-40. PubMed ID: 24584370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast media-enhanced power Doppler sonography for evaluation of hemangiomas and malignant tumors in the liver.
    Karabacakoglu A; Karakose S; Cil AS; Kaya A
    J Gastroenterol Hepatol; 2003 Jan; 18(1):92-8. PubMed ID: 12519230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of hepatic tumors by color Doppler imaging: role of the maximum velocity and the pulsatility index of the intratumoral blood flow signal.
    Kudo M; Tochio H; Zhou P
    Intervirology; 2004; 47(3-5):154-61. PubMed ID: 15383724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma.
    Tanaka S; Kitamra T; Yoshioka F; Kitamura S; Yamamoto K; Ooura Y; Imaoka T
    Ultrasound Med Biol; 1995; 21(2):157-60. PubMed ID: 7571125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions.
    Hosten N; Puls R; Lemke AJ; Steger W; Zendel W; Zwicker C; Felix R
    J Clin Ultrasound; 1999; 27(3):107-15. PubMed ID: 10064407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors.
    Choi BI; Kim TK; Han JK; Chung JW; Park JH; Han MC
    Radiology; 1996 Jul; 200(1):55-8. PubMed ID: 8657945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Doppler sonography in the diagnosis of liver tumors].
    Arai K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Mar; 52(3):320-37. PubMed ID: 1315951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US.
    Lencioni R; Pinto F; Armillotta N; Bartolozzi C
    Radiology; 1996 Nov; 201(2):353-8. PubMed ID: 8888222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhanced color flow findings in small hepatocellular carcinoma].
    Maruyama H; Matsutani S; Ebara M; Saisho H
    Nihon Rinsho; 1998 Apr; 56(4):967-74. PubMed ID: 9577618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Color flow Doppler characterization of focal hepatic lesions.
    Nino-Murcia M; Ralls PW; Jeffrey RB; Johnson M
    AJR Am J Roentgenol; 1992 Dec; 159(6):1195-7. PubMed ID: 1332456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
    Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
    Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between microbubble contrast-enhanced color doppler sonography and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: preliminary results.
    Kitamura H; Kawasaki S; Nakajima K; Ota H
    J Clin Ultrasound; 2002 Oct; 30(8):465-71. PubMed ID: 12242734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors.
    Kudo M; Tomita S; Tochio H; Mimura J; Okabe Y; Kashida H; Hirasa M; Ibuki Y; Todo A
    AJR Am J Roentgenol; 1992 Jan; 158(1):65-74. PubMed ID: 1309220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.